We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Criteria for Diagnosing Celiac Disease May Be Too Stringent

By Labmedica staff writers
Posted on 29 May 2008
Current diagnostic criteria for celiac disease include small intestinal mucosal membrane villus atrophy and inflammation. More...
According to new evidence, these criteria may be too stringent, leaving patients with the disease undiagnosed and untreated.

Celiac disease is an autoimmune disorder in the small intestine triggered by the consumption of a common protein called gluten--found in bread, pasta, and many other common foods. Though the disease is genetic, it often goes undiagnosed. Symptoms of gluten toxicity include diarrhea, weight loss, abdominal pain, anemia, and oral ulcerations. While most people with celiac disease do well on a gluten-free diet, the level of gluten avoidance needed to maintain disease remission represents a significant burden

To determine if the current diagnostic criteria are too narrow, 145 patients suspected of having celiac disease were examined. Seventy-one of the patients were found to be endomysial antibody-positive, and of those only 48 met the criteria under the current definition of celiac disease. The remaining 23 patients were divided randomly into two groups. One group was placed on a gluten-free diet and the other continued a regular diet that included gluten.

Patients were biopsied again after one year following their respective diets. Patients on the gluten-free diet were asymptomatic and their endomysial antibodies disappeared, as did their small intestinal mucosal inflammation. However, the patients on a regular diet continued to experience symptoms. These patients continued to be endomysial antibody-positive and showed further deterioration of the small bowel membrane, mucosal inflammation, and gluten-induced lesions in the bowel.

According to Markku Maki, M.D., professor of pediatrics at the University of Tampere, Celiac Disease Study Group (UTa, Tampere, Finland) patients on the gluten-free diet elected to continue the diet after the yearlong study, and the patients on the regular diet elected to eliminate gluten from their diet and over time became symptom free, endomysial antibody-free, and experienced healing of the mucosal membrane.

Scientists believe that over time, patients who are endomysial antibody-positive may develop the gut injury that makes up the current criteria for diagnosing celiac disease. "By redefining the criteria for celiac disease, we can treat patients before they begin to experience the most severe symptoms and signs of the disease,” said Dr. Maki.

This study was presented at the Digestive Disease Week (DDW) in San Diego (CA, USA) which took place from May 17-22, 2008.


Related Links:
University of Tampere

Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Electrolyte Analyzer
CBS-4000 (CBS-400)
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.